Pubblicazioni
2025
Rinaldi F., Balboni B., Varignani G., Milordini G., Marotta R., Girotto S., Cavalli A.
An integrative structural study of RAD52, an emerging target in anticancer drug discovery
XXIX National Meeting on Medicinal Chemistry of the Italian Chemistry Society
Poster
Conference
2025
Rinaldi F., Balboni B., Girotto S., Cavalli A.
An integrative structural study of RAD52, an emerging target in anticancer drug discovery
XXIX National Meeting on Medicinal Chemistry of the Italian Chemistry Society
Poster
Conference
2025
Rinaldi F., Franco P., Veronesi M., Romeo E., Bresciani V., Varignani G., Catalano F., Bernetti M., Masetti M., Langer J. D., Girotto S., Cavalli A.
Breaking new ground into RAD51–BRC repeats interplay in Homologous Recombination
Research Square
Article
E-print Archive
2025
Milordini G., Zacco E., Armaos A., Di Palma F., Masi M., Gilodi M., Rupert J., Broglia L., Varignani G., Oneto M., Scotto M., Marotta R., Girotto S., Cavalli A., Tartaglia G.G.
Computationally-designed aptamers targeting RAD51-BRCA2 interaction inhibit RAD51 nuclear recruitment
bioRxiv
2025
Torielli L., Castelli M., Milani F., Heritz J.A., Cayaban S.J., Hernandez J., Serapian S.A., Magni A., Frasnetti E., Doria F., Pirota V., Wengert L.A., Woodford M.R., Lodigiani G., Bergamaschi G., Veronesi M., Bandiera T., Girotto S., Paladino A., Prodromou C., Backe S.J., Bourboulia D., Canciani A., Arrigoni C., Lolicato M., Gestwicki J.E., Mollapour M., Colombo G.
Design of multi-target peptide modulators for protein chaperone networks
Structure
2025
Bresciani V., Rinaldi F., Franco P., Girotto S., Cavalli A., Langer J. D., Masetti M., Bernetti M.
Dissecting the RAD51-BRC4 Interaction Landscape through Integrative Molecular Simulations and Experimental Biophysics
Journal of Chemical Information and Modeling
Article
Journal
2025
Rinaldi F., Balboni B., Marotta R., Girotto S., Cavalli A.
Elucidating RAD52 architecture through an integrated structural biology approach
51st Meeting of the Italian Crystallographic Association
Poster
Conference
2025
Quatraccioni M., Ocello R., Falchi F., Previtali V., Veronesi M., Varignani G., Margaroli N., Masi M., Scarpelli R., Girotto S., Cavalli A.
In search of small molecules targeting RAD52 for synthetic lethality (P120)- September 14-17, 2025, Parma (Italy)
XXIX National Meeting on Medicinal Chemistry
Poster
Conference
2025
Bresciani V., Rinaldi F., Franco P., Girotto S., Cavalli A., Langer J. D., Masetti M., Bernetti M.
Integrating computational and experimental biophysics reveals novel insights into the RAD51-BRC4 interaction
BiorXiv
2025
Masi M., Poppi L., Previtali V., Nelson S.R., Wynne K., Varignani G., Falchi F., Veronesi M., Albanesi E., Tedesco D., De Franco F., Ciamarone A., Myers S.H., Ortega J.A., Bagnolini G., Ferrandi G., Farabegoli F., Tirelli N., Di Stefano G., Oliviero G., Walsh N., Roberti M., Girotto S., Cavalli A.
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity
Cell Death Discovery, vol. 11, (no. 1)
2025
Codino A., Spagnoletti L., Olobardi C., Cuomo A., Santos-Rosa H., Palomba M., Margaroli N., Girotto S., Scarpelli R., Luan S.-L., Crocco E., Bianchini P., Bannister A.J., Gustincich S., Kouzarides T., Rizzo R., Barbieri I., Cremisi F., Vignali R., Pandolfini L.
METTL9 sustains vertebrate neural development primarily via non-catalytic functions
Nature Communications, vol. 16, (no. 1)
2025
Rinaldi F., Bresciani V., Franco P., Veronesi M., Bernetti M., Masetti M., Langer J., Cavalli A., Girotto S.
Probing the BRC repeats RAD51 interaction by integrating computational and experimental biophysics
The 49th FEBS Congress
Poster
Conference
2025
Di Martino R.M.C., Russo D., Penna I., Demuro S., Dalle Vedove A., Spagnuolo R., Ottonello G., Bertozzi S.M., Summa M., Desantis J., Valeri A., Pruccoli L., Tripathi S.K., Tarozzi A., Storici P., Girotto S., Bertorelli R., Armirotti A., Cruciani G., Bandiera T., Cavalli A., Bottegoni G.
Rational optimization of D3R/GSK-3β dual target-directed ligands as potential treatment for bipolar disorder: Design, synthesis, X-ray crystallography, molecular dynamics simulations, in vitro ADME, and in vivo pharmacokinetic studies
European Journal of Medicinal Chemistry, vol. 297
2025
Romeo E., Saccoliti F., Andonaia A., Allegretta C., Occello R., Pastorino C., Pedemonte N., Girotto S., Falchi F., Laselva O., Bandiera T., Bertozzi F.
Target identification with live-cell photo-affinity labelling and elucidation of the mechanism of action of the CFTR corrector ARN23765
EFMC-ISCB
Poster
Conference
2025
Quatraccioni M., Ocello R., Falchi F., Previtali V., Veronesi M., Varignani G., Margaroli N., Masi M., Scarpelli R., Girotto S., Cavalli A.
Targeting RAD52 for synthetic lethality: discovery of a novel small molecule as a promising inhibitor for cancer therapy (P310)- August 31-September 4, 2025, Porto (Portugal)
X EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry
Poster
Conference